Stamford, CT -- (SBWIRE) -- 09/11/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Applied DNA Sciences Inc (OTCBB:APDN), Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY), Advaxis, Inc. (OTCBB:ADXS), Affymax, Inc. (OTCMKTS:AFFY)
Applied DNA Sciences Inc (OTCBB:APDN) decreased -1.56% at the price of $0.120 recently on a traded volume of 2.98 million shares, in comparison to 3.09 million shares of average trading volume. So far this year, the stock is down over -43.1%.
The company has a total market capitalization of $88.93 million and its total outstanding shares are 744.22 million. Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions in Europe and the United States.
Has APDN Found The Bottom and Ready To Move Up? Find Out Here
Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) soared 0.48% at the trading price of $66.33 on a traded volume of 253,728.00 shares till now, whereas its average trading volume is 574,544.00 shares. In the last three months, the stock is down -0.97%. The Intra-day range for the stock is $66.00 and $66.34. Nestlé S.A., together with its subsidiaries, provides nutrition, health, and wellness products worldwide. The company offers baby foods primarily under the Cerelac, Gerber, Gerber Graduates, NaturNes, and Nestum brands; bottled water principally under the Nestlé Pure Life, Perrier.
For How Long NSRGY Gloss will Attract Investors? Find out via this report
Advaxis, Inc. (OTCBB:ADXS) jumped up 28.41% at the $8.86 recently. So far in three months, the stock is up 69.52%. The 52-week range for the stock is $2.60 and $19.38. Its introductory price for the day was $6.88, with the overall traded volume of 133,993.00 shares. Advaxis, Inc., a clinical development stage biotechnology company, engages in the development of immunotherapies for cancer and infectious diseases.
Will ADXS Continue To Move Higher? Find Out Here
Affymax, Inc. (OTCMKTS:AFFY) after opening its shares at the price of $1.49, jumped up 1.32% , its recent trading price was $1.53 for the day. The stock moved on a traded volume of 315,897.00 shares, in comparison to 1.28 million shares of average trading volume.
The 52-week range for the stock is $0.78 and $27.74. Its introductory price for the day was $1.49. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Why Should Investors Buy AFFY After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks:
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)